UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated

American journal of transplantation, 2016-04, Vol.16 (4), p.1285-1293

2016

Volltextzugriff (PDF)

Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (10), p.1397-1408

2018

Volltextzugriff (PDF)

Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation

American journal of transplantation, 2016-02, Vol.16 (2), p.484-496

2016

Volltextzugriff (PDF)

A Need for Biomarkers of Operational Tolerance in Liver and Kidney Transplantation

American journal of transplantation, 2012-06, Vol.12 (6), p.1370-1377

2012

Volltextzugriff (PDF)

Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C

American journal of transplantation, 2014-02, Vol.14 (2), p.375-383

2014

Volltextzugriff (PDF)

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti‐viral therapy with an interferon‐free regimen

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (8), p.1156-1161

2017

Volltextzugriff (PDF)

Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct‐acting antiviral therapy—authors' reply

Alimentary pharmacology & therapeutics, 2017-06, Vol.45 (12), p.1559-1560

2017

Volltextzugriff (PDF)

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2016-02, Vol.43 (3), p.364-374

2016

Volltextzugriff (PDF)

Comparison of Transcriptional and Blood Cell‐Phenotypic Markers Between Operationally Tolerant Liver and Kidney Recipients

American journal of transplantation, 2011-09, Vol.11 (9), p.1916-1926

2011

Volltextzugriff (PDF)

ATG‐Fresenius Treatment and Low‐Dose Tacrolimus: Results of a Randomized Controlled Trial in Liver Transplantation

American journal of transplantation, 2010-10, Vol.10 (10), p.2296-2304

2010

Volltextzugriff (PDF)

Early predictive factors of corticosteroids response in patients with severe/acute or fulminant autoimmune hepatitis

Journal of hepatology, 2017, Vol.66 (1), p.S549-S549

2017

Volltextzugriff (PDF)

Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy

American journal of transplantation, 2010-12, Vol.10 (12), p.2604-2614

2010

Volltextzugriff (PDF)

Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation

Transplant infectious disease, 2016-06, Vol.18 (3), p.471-479

2016

Volltextzugriff (PDF)

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

The Lancet (British edition), 2015-10, Vol.386 (10003), p.1537-1545

2015

Volltextzugriff (PDF)

Interferon-free therapy is effective and safe for hepatitis C recurrence in liver transplant hepatitis C virus/human immunodeficiency virus coinfected recipients: a case-control study

Journal of hepatology, 2017, Vol.66 (1), p.S189-S189

2017

Volltextzugriff (PDF)

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Journal of hepatology, 2017, Vol.66 (1), p.S717-S717

2017

Volltextzugriff (PDF)

Prevalence and Management of Drug-Drug Interactions (DDIs) with Ombitasvir (OBV), Paritaprevir/R (PRV/r) ± Dasabuvir (DBV) ± Ribavirin (RBV) in Pacients with Chronic Hepatitis C in Real-Life Clinical Practice

Journal of hepatology, 2016, Vol.64 (2), p.S761-S761

2016

Volltextzugriff (PDF)

Efficacy and Tolerability of Interferon-Free Antiviral Therapy in Kidney Transplant (KT) Recipients with Chronic Hepatitis C: Real-Life Data from the Spanish National Registry (HEPA-C)

Journal of hepatology, 2016, Vol.64 (2), p.S793-S794

2016

Volltextzugriff (PDF)

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

Journal of hepatology, 2016, Vol.64 (2), p.S273-S273

2016

Volltextzugriff (PDF)

O023 : Repeated measurement of non-invasive fibrosis markers to assess hepatitis C progression and clinical outcomes

Journal of hepatology, 2015-04, Vol.62, p.S202-S202

2015

Volltextzugriff (PDF)

P0061 : Treatment with new all-oral direct acting antivirals in HCV-recurrence in liver transplant-setting induces a reduction of immunosuppressive drug levels

Journal of hepatology, 2015-04, Vol.62, p.S315-S315

2015

Volltextzugriff (PDF)

LP24 : Safety, efficacy and impact on liver function of simeprevir (SMV) in combination with daclatasvir (DCV) or sofosbuvir (SOF) in patients with severe hepatitis C recurrence after liver transplantation (LT): results from compassionate use in europe

Journal of hepatology, 2015-04, Vol.62, p.S275-S276

2015

Volltextzugriff (PDF)

LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease

Journal of hepatology, 2015-04, Vol.62, p.S263-S264

2015

Volltextzugriff (PDF)

Ledipasvir/Sofosbuvir for Recurrent Hepatitis C in Liver Transplant Recipients: A Real-Life Spanish Multicentre Experience

Journal of hepatology, 2016, Vol.64 (2), p.S794-S795

2016

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(111)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(49)
Humans
(44)
Female
(33)
Male
(28)
Middle Aged
(23)
Gastroenterology And Hepatology
(20)
Adult
(19)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Aged
(15)
Surgery
(15)
Gastroenterology & Hepatology
(14)
Transplantation
(13)
Liver Transplantation
(11)
Patients
(11)
Follow-Up Studies
(9)
Hepatitis
(9)
Retrospective Studies
(9)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated

Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone

Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation

A Need for Biomarkers of Operational Tolerance in Liver and Kidney Transplantation

Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti‐viral therapy with an interferon‐free regimen

Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct‐acting antiviral therapy—authors' reply

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C

Comparison of Transcriptional and Blood Cell‐Phenotypic Markers Between Operationally Tolerant Liver and Kidney Recipients

ATG‐Fresenius Treatment and Low‐Dose Tacrolimus: Results of a Randomized Controlled Trial in Liver Transplantation

Early predictive factors of corticosteroids response in patients with severe/acute or fulminant autoimmune hepatitis

Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy

Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

Interferon-free therapy is effective and safe for hepatitis C recurrence in liver transplant hepatitis C virus/human immunodeficiency virus coinfected recipients: a case-control study

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Prevalence and Management of Drug-Drug Interactions (DDIs) with Ombitasvir (OBV), Paritaprevir/R (PRV/r) ± Dasabuvir (DBV) ± Ribavirin (RBV) in Pacients with Chronic Hepatitis C in Real-Life Clinical Practice

Efficacy and Tolerability of Interferon-Free Antiviral Therapy in Kidney Transplant (KT) Recipients with Chronic Hepatitis C: Real-Life Data from the Spanish National Registry (HEPA-C)

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study

O023 : Repeated measurement of non-invasive fibrosis markers to assess hepatitis C progression and clinical outcomes

P0061 : Treatment with new all-oral direct acting antivirals in HCV-recurrence in liver transplant-setting induces a reduction of immunosuppressive drug levels

LP24 : Safety, efficacy and impact on liver function of simeprevir (SMV) in combination with daclatasvir (DCV) or sofosbuvir (SOF) in patients with severe hepatitis C recurrence after liver transplantation (LT): results from compassionate use in europe

LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease

Ledipasvir/Sofosbuvir for Recurrent Hepatitis C in Liver Transplant Recipients: A Real-Life Spanish Multicentre Experience

Suchergebnisse filtern